Oral Mucositis, Pain and Xerostomia in Patients with Head and Neck Cancer who Received Chemoradiotherapy with or without Cetuximab

Table 2: Mucositis, Pain and Xerostomia During Chemo-RT. (n=49)

PARAMETER	Group A		Group B		p-value^*
PARAMETER	N	%	N	%	p-value^*
Mucositis
Grade ≤2	10	40	5	20.8	NS
Severe, grade 3, 4	15	60	19	79.2	NS
Pain
Mild/Moderate	9	36	10	41.7	NS
Severe	16	64	14	58.3	NS
Xerostomia
Mild/Moderate	12	48	17	70.8	NS
Severe	13	52	7	29.2	NS
Use of antifungals	20	80	20	83.3	NS
Use of antivirals	20	80	18	75	NS
RT interruptions-overall	4	16	5	20.8	NS
RT interruptions due to mucositis	3	12	4	16.7	NS

^* based on Chi-square test Oral toxicity following the completion of RT (Table 3 and Table 4)